SEGMENT REPORTING - Schedule of Reportable Segment Information and Reconciliation of Segment Information (Details) - USD ($) $ in Millions	12 Months Ended			24 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2024
Segment Reporting [Line Items]
Net Sales	$ 6,720	$ 7,104	$ 7,093
Cost of products sold	3,876	3,891	4,045
Interest income	8	9	23
Interest expense	(130)	(88)	(90)
Loss on divestiture	0	(118)	(240)
Pension settlement charge	0	0	(171)
Streamlined operating model			(32)
Digital capabilities and productivity enhancements investment	(59)	(111)	(108)
Earnings before income taxes	791	1,078	398
(Income) Loss from equity investees included in Other (income) expense, net	(3)	(4)	(5)
Total assets	7,794	5,561
Capital expenditures	207	220	212
Depreciation and amortization	247	219	235
Stock-based compensation	48	81	74
Cyberattack
Segment Reporting [Line Items]
Cyberattack costs, net of insurance recoveries		70	$ (29)
Cyberattack | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			100.00%
Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			100.00%	100.00%
GOJO Industries
Segment Reporting [Line Items]
Acquisition and integration costs	(58)
Health and Wellness
Segment Reporting [Line Items]
Net Sales	2,697	2,697	$ 2,485
Household
Segment Reporting [Line Items]
Net Sales	1,787	2,001	1,950
Lifestyle
Segment Reporting [Line Items]
Net Sales	1,123	1,303	1,275
International
Segment Reporting [Line Items]
Net Sales	1,113	1,065	1,162
Operating Segments
Segment Reporting [Line Items]
Net Sales	6,720	7,066	6,872
Segment adjusted EBIT	1,191	1,565	1,354
Operating Segments | Health and Wellness
Segment Reporting [Line Items]
Net Sales	2,697	2,697	2,485
Cost of products sold	1,390	1,273	1,211
Other segment items	629	584	555
Segment adjusted EBIT	678	840	719
(Income) Loss from equity investees included in Other (income) expense, net	0	0	0
Total assets	3,615	1,217
Capital expenditures	60	66	47
Depreciation and amortization	79	58	58
Stock-based compensation	16	16	$ 14
Operating Segments | Health and Wellness | Cyberattack | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			30.00%
Operating Segments | Health and Wellness | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			3.00%	5.00%
Operating Segments | Household
Segment Reporting [Line Items]
Net Sales	1,787	2,001	$ 1,950
Cost of products sold	1,208	1,277	1,276
Other segment items	387	399	414
Segment adjusted EBIT	192	325	260
(Income) Loss from equity investees included in Other (income) expense, net	0	0	0
Total assets	1,072	1,091
Capital expenditures	75	78	84
Depreciation and amortization	85	81	77
Stock-based compensation	11	12	$ 11
Operating Segments | Household | Cyberattack | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			24.00%
Operating Segments | Household | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			2.00%	2.00%
Operating Segments | Lifestyle
Segment Reporting [Line Items]
Net Sales	1,123	1,303	$ 1,275
Cost of products sold	584	648	644
Other segment items	331	365	378
Segment adjusted EBIT	208	290	253
(Income) Loss from equity investees included in Other (income) expense, net	0	0	0
Total assets	1,128	1,103
Capital expenditures	33	37	36
Depreciation and amortization	27	25	24
Stock-based compensation	8	8	$ 8
Operating Segments | Lifestyle | Cyberattack | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			23.00%
Operating Segments | Lifestyle | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			0.00%	2.00%
Operating Segments | International
Segment Reporting [Line Items]
Net Sales	1,113	1,065	$ 1,162
Cost of products sold	708	668	743
Other segment items	292	287	297
Segment adjusted EBIT	113	110	122
(Income) Loss from equity investees included in Other (income) expense, net	(3)	(4)	(5)
Total assets	1,316	1,329
Capital expenditures	30	26	21
Depreciation and amortization	43	42	45
Stock-based compensation	6	6	$ 6
Operating Segments | International | Cyberattack | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			8.00%
Operating Segments | International | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			4.00%	11.00%
Corporate and Other
Segment Reporting [Line Items]
Net Sales	0	38	$ 221
Segment adjusted EBIT	(161)	(249)	(309)
(Income) Loss from equity investees included in Other (income) expense, net	0	0	0
Total assets	663	821
Capital expenditures	9	13	24
Depreciation and amortization	13	13	31
Stock-based compensation	$ 7	$ 39	$ 35
Corporate and Other | Cyberattack | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			15.00%
Corporate and Other | Restructuring and Related Costs Benchmark | Product Concentration Risk
Segment Reporting [Line Items]
Concentration percentage			91.00%	80.00%